Jack W. Callicutt

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

GALT

Current role

CFO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Galectin Therapeutics Inc (GALT)	Chief Financial Officer	$397,333	$120,000	$144,740	—	—	$54,872	$716,945
2023	Galectin Therapeutics Inc (GALT)	Chief Financial Officer	$364,000	$110,400	—	$39,946	—	$47,073	$561,419
2022	Galectin Therapeutics Inc (GALT)	Chief Financial Officer	$318,508	$96,000	—	$73,940	—	$78,116	$566,564
2021	Galectin Therapeutics Inc (GALT)	Chief Financial Officer	$302,100	$90,630	—	$235,126	—	$78,062	$705,918
2020	Galectin Therapeutics Inc (GALT)	Chief Financial Officer	$300,675	$236,050	—	$110,190	—	$73,457	$720,372
2019	Galectin Therapeutics Inc (GALT)	Chief Financial Officer	$285,000	$233,451	—	$191,568	—	$68,105	$778,124
2018	Galectin Therapeutics Inc (GALT)	Chief Financial Officer	$275,278	$213,750	—	$715,319	—	$62,150	$1,266,497
2017	Galectin Therapeutics Inc (GALT)	Chief Financial Officer	$260,000	$91,163	—	—	—	$54,848	$406,011

No earnings-call appearances or filed executive changes recorded yet.